在接受新辅助化疗的浸润性乳腺癌女性中,基线乳腺X线和超声特征是否与无转移生存相关
本研究基于伦理批准的前瞻性研究数据,纳入171例女性172个接受新辅助化疗的浸润性乳腺癌,基线超声和乳腺X线由对结局盲法的经验丰富乳腺放射科医生评估。中位随访6.0年,55例发生转移。乳腺X线钙化、超声远端声影和超声皮肤增厚与较差的無转移生存显著相关,而乳腺X线毛刺征、超声大小和剪切波弹性成像硬度与無转移生存无显著关联。
要点
- 乳腺X线钙化者6年無转移生存50% vs 无钙化者69%(p=0.043)。
- 超声远端声影者6年無转移生存47% vs 无声影者73%(p=0.025)。
- 超声皮肤增厚者6年無转移生存52% vs 无增厚者68%(p=0.032)。
核心结论
- 在接受新辅助化疗的浸润性乳腺癌女性中,乳腺X线钙化、超声远端声影和超声皮肤增厚与较差的無转移生存相关;乳腺X线毛刺征、超声大小和剪切波弹性成像硬度与無转移生存无显著关联。
研究设计与样本
- 前瞻性研究(经伦理批准),纳入171例女性172个接受新辅助化疗的浸润性乳腺癌,诊断时无转移;基线行超声和乳腺X线检查,由对结局盲法的经验丰富乳腺放射科医生评估;通过计算机记录确定转移发生;采用Kaplan-Meier生存曲线和ROC分析。
关键影像表现/征象
- 乳腺X线钙化者6年無转移生存50%,无钙化者69%(p=0.043)。
- 超声远端声影者6年無转移生存47%,无声影者73%(p=0.025)。
- 超声皮肤增厚者6年無转移生存52%,无增厚者68%(p=0.032)。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
OBJECTIVES: To identify associations between baseline ultrasound (US) and mammographic features and metastasis free survival (MFS) in women receiving neo-adjuvant chemotherapy (NACT) for breast cancer.
METHODS: The data were collected as part of an ethically approved prospective study. Women with invasive breast cancer receiving NACT who were metastasis free at diagnosis were included. Baseline US and mammography were performed. Imaging was assessed by an experienced breast radiologist who was blinded to outcomes. US imaging features documented included posterior effect, skin thickening, size and stiffness using shear wave elastography (SWE). The mammographic features documented were spiculation and microcalcification. The development of metastatic disease was ascertained from computer records. Statistical analysis was performed using Kaplan Meier survival curves and Receiver Operator Characteristic (ROC) analysis.
RESULTS: 171 women with 172 cancers were included in the study and 55 developed metastatic disease. Mean follow-up was 6.0 years. Women with mammographic calcification had significantly poorer metastasis free survival (MFS) compared to women without calcification (p = 0.043, 6 yr MFS 50 % vs 69 %). Women bearing cancer with distal shadowing had poorer MFS than women without shadowing (p = 0.025, 6 yr MFS 47 % vs. 73 %). Women with US skin thickening had poorer MFS compared to women without skin thickening (p = 0.032, 6 yr MFS 52 % vs. 68 %). Mammographic spiculation, US size and stiffness at SWE had no significant association with MFS.
CONCLUSION: We have identified mammographic and US features associated with MFS in women receiving NACT. Such information may be useful when counselling patients about the benefits and risks of NACT.
引用
- Evans A, Sim YT, Whelehan P, et al. Are baseline mammographic and ultrasound features associated with metastasis free survival in women receiving neoadjuvant chemotherapy for invasive breast cancer? Eur J Radiol. 2021. PMID: 34091135. doi:10.1016/j.ejrad.2021.109790
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。